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ABSTRACT
Background: Patient-generated outcome measures have
been developed in an effort to capture the individualistic
nature of health-related quality of life (HRQoL). These
measures differ from traditional HRQoL instruments
in that they allow patients to individually deﬁne HRQoL
domains or weights. Nevertheless, application of these
measures may be challenging, particularly in a clinical
trial setting.
Objective: The objective of this study was to provide a
critical review of the following patient-generated outcome
measures: Patient-Generated Index (PGI), Schedule for
the Evaluation of Individual Quality of Life (SEIQoL),
Repertory Grid, and Asthma Quality of Life Question-
naire (AQLQ).
Methods: We conducted a systematic literature review of
the Medline and Olga databases and the journal Quality
of Life Research and consulted experts. We abstracted
data from eligible studies on the instruments’ content,
psychometric properties, and applicability in a clinical
trial setting.
Results: The SEIQoL has shown to be reliable, valid, and
responsive, but the PGI has not. Both instruments have
poor practicality and have not been used in a clinical trial.
The Repertory Grid’s psychometric properties have not
been well studied. The AQLQ is in part patient-generated
and has been used in clinical trials. Nevertheless, the prac-
ticality of the individualized section is poor owing to the
issue of missing data. All four instruments fail to provide
a form of standardization needed for estimating popula-
tion effects in a clinical trial.
Conclusion: The applicability of patient-generated out-
come measures in a clinical trial setting remains question-
able. Patient-generated outcome measures appear to be
useful primarily in complementing traditional HRQoL
measures, guiding individual patient treatment decisions,
and assisting the design of new measures.
Keywords: AQLQ, health-related quality of life, indi-
vidualized measure, Patient-Generated Index, patient-
generated outcome measure, Repertory Grid, SEIQoL.
Introduction
The use of patient-reported outcomes to evalu-
ate health-care interventions is becoming more
accepted in the medical community, particularly
in clinical trials. Health-related quality of life
(HRQoL) instruments are designed to capture a
broad range of quality of life dimensions, from bur-
den of symptoms to social functioning. Neverthe-
less, all traditional instruments assess QoL using
at least one of four domains: physical function,
emotional state, social interaction, and somatic
sensation [1].
Although traditional HRQoL measures have
been widely used and often validated, they fail to
capture the uniqueness of individuals. They focus
on the individual’s perception of his or her quality
of life through the lens of standardized models and
preselected domains [2]. In contrast, patient-gener-
ated outcomes, also known as individualized ques-
tionnaires, attempt to capture aspects of quality of
life that are most important to the individual. These
instruments do not consist of predeﬁned domains or
weights. Instead, domains and/or weights are elic-
ited from each individual subject and are then used
to derive an overall quality-of-life score. Given the
growing interest in the use of patient-reported out-
comes in clinical trials, the use of patient-generated
outcomes in clinical trials should be considered. The
objective of this study was to perform a critical
review of these instruments and assess their appli-
cability in a clinical trial setting.
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Methods
We utilized the book entitled Individual Quality of
Life Approaches to Conceptualisation and Assess-
ment to identify patient-generated outcomes [3]. We
included instruments that elicited domains and/or
weights from individual patients and derived an
overall QoL score. Four instruments were excluded
because they consisted of only predeﬁned domains
and weights, Audit-Diabetes Dependent Quality of
Life (ADDQoL), the Quality of Life Index (QLI),
SmithKline Beecham Quality of Life Questionnaire
(SBQoL), and Wisconsin Quality of Life Question-
naire (W-QLI), and four instruments were excluded
because they did not derive an overall QoL score,
content analysis methods, goal attainment meas-
ures, the Subjective Quality of Life Proﬁle (SQLP),
and the Chronic Respiratory Disease Questionnaire
(CRQ). The Patient-Generated Index (PGI), the
Schedule for the Evaluation of Individual Quality of
Life (SEIQoL), the Repertory Grid, and the Asthma
Quality of Life Questionnaire (AQLQ) met our
inclusion criteria.
We then conducted a systematic literature review
in August 2001 using Medline and Olga computer-
ized databases to search for studies containing the
key words “Patient-Generated Index,” “SEIQoL,”
“Repertory Grid,” and “AQLQ.” We selected stud-
ies that were original research articles and written in
English. To ensure that all relevant studies were
obtained, we searched the references cited at the end
of studies and manually searched the Quality of
Life Research journal (1990–2001). We also con-
sulted experts in the ﬁeld, e.g., instruments’ devel-
opers, for any unpublished studies and additional
references. The AQLQ is a hybrid instrument, con-
sisting of both traditional and patient-generated
measures, and because our primary interest was to
evaluate the patient-generated items, we chose only
those studies that explicitly discussed the individu-
alized section of the instrument. We abstracted data
on the instruments’ content, psychometric proper-
ties, and applicability in a clinical trial setting.
We examined validity and reliability and, in
particular, examined responsiveness and practical-
ity to determine the instruments’ applicability in a
clinical trial setting. The instruments’ validity was
addressed using three categories: criterion validity,
content validity and construct validity. Criterion
validity was assessed by looking for a moderate
correlation, .3 to .5, between scores of the instru-
ment and a criterion measure, such as the SF-36 or
disease-speciﬁc instruments. Content validity was
assessed by evaluating the evidence of the content
of an instrument, which was appropriate relative
to its intended use (> .70). Construct validity was
addressed by looking for evidence that the instru-
ment’s scores supported theoretical implications.
The reliability of the instruments was examined by
assessing internal reliability, typically by evaluating
Cronbach’s coefﬁcient alpha and reproducibility,
e.g., a test–retest reliability of >.70. Responsiveness
was evaluated by assessing the instrument’s ability
to capture change compared to traditional instru-
ments, and practicality was assessed by examining
interviewer and respondent burden by examining
the level of missing data and completion time [4].
We also examined the instruments’ current use in
QoL research and their ability to make compari-
sons across individuals and estimate population
effects.
Results
Description of Measures
PGI. The conceptual basis of the PGI comes from
Ken Calman, United Kingdom’s Chief Medical
Ofﬁcer, who deﬁned QoL as “the extent to which
our hopes and ambitions are matched by experi-
ence” in 1984 [5]. The creators of the PGI
incorporated Calman’s beliefs and developed an
individualized, patient-centered outcome measure
that moved away from the traditional measures of
impairment and disability and toward the assess-
ment of overall QoL. They believed that this would
not only allow outcome measurement to capture the
outcomes that have some relevance and meaning to
patients’ lives, but also revolutionize cost-effective-
ness by redeﬁning effectiveness from the patient’s
perspective.
The instrument can be either self-completed or
interviewer administered [6]. Patients are ﬁrst asked
to list the ﬁve most important areas or activities of
their lives affected by their condition (Fig. 1). They
are also given a trigger list of the areas most fre-
quently mentioned by patients with the same con-
dition. In addition, a sixth area is provided to
represent all other aspects of life that are not cap-
tured in the ﬁrst ﬁve areas and may include non-
health aspects of life. Patients are then asked to rate
how their current condition matches their expecta-
tions in each of the six areas of life using a scale of
0 to 10. To obtain the relative importance of poten-
tial improvements in the six areas, patients are
asked to imagine that they are given 12 points to
improve their score in any of these six areas of life.
They can distribute these points in any manner they
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choose, but cannot use more or less than 12 points
[5,7].
The overall score, also known as the index, is cal-
culated by taking the weighted sum of each area.
The score ranges from 0 to 10, where 0 reﬂects that
most reality falls short of patients’ hopes and expec-
tations and 10 is the greatest extent to which reality
matches expectations. If there are missing data then
the overall score cannot be calculated. An example
of the PGI given to a young man with low back pain
is provided in Table 1. This man’s reality moder-
ately matches his expectations.
SEIQoL. The SEIQoL was developed based on
the social judgment theory known as judgment
analysis. Judgment analysis can be used to quantify
the relative importance of a number of factors to a
particular judgment or decision. The SEIQoL is
completed in three stages. In the ﬁrst stage, individ-
uals are asked to choose ﬁve areas of life they con-
sider most important in assessing their QoL,
referred to as the “elicited cues” (Fig. 2). If patients
need assistance, a list of possibilities is read. In the
second stage, individuals are asked to rate their cur-
rent status for each cue on a vertical analog scale
(VAS) and their current overall QoL on a horizontal
VAS. In the third stage, the patients rate the overall
QoL for 30 randomly generated hypothetical pro-
ﬁles to quantify the relative contribution of each
elicited cue to the overall judgment of QoL for that
individual. This task takes 30 minutes on average to
complete (Fig. 2). The relative weight attached to
each cue is estimated by the multiple regression
analysis and the weights sum to 1.0.
A global, “elicited” QoL score is then derived by
multiplying each cue weight by the individual’s cur-
rent self-rating on that particular cue and summing
these across the ﬁve cues, with scores = 0 to 100. If
there are missing data then the overall score cannot
be calculated. The program also tests for internal
validity (R2) by measuring the variance of the QoL
judgment and tests for internal reliability by calcu-
lating Pearson’s coefﬁcient for 10 sets of hypothet-
ical scenarios taken at random among the 30
hypothetical scenarios presented to the patient [8].
Repertory Grid. Kelly developed the Repertory
Grid by deriving it from the personal construct the-
ory. Within the framework of the theory, thoughts
are described as being made up of two types: ele-
ments and constructs. Elements are the objects of
people’s thoughts and constructs are the qualities
which people use to think about and describe
elements. In this context, an interviewer elicits
constructs of relevance and importance to the indi-
vidual’s QoL.
Thunedborg et al. [9] modiﬁed the Repertory
Grid by adding ﬁxed elements and constructs. The
investigators a priori formulated 17 ﬁxed elements
covering self, other, e.g., closest friend, and projec-
tive perspectives, e.g., person who you think lives an
ideal life, and 12 ﬁxed constructs covering the phys-
ical, cognitive, affective, social, and economic life
domains (Fig. 3). Patients are encouraged to add
up to three elements and 13 constructs. The inter-
viewer elicits the free constructs using the triad tech-
nique, which requires the patient to describe ways
in which three elements are similar or differ from
each other on QoL domains. Patients then rate the
strength of association between each element and
Figure 1 Stages of the PGI.
Stage 1  
 
          
Stage 2 
 
 
List 5 areas Rate how your current condition 
 
          
Stage 3 
or activities matches your expectations in  
     
Distribute 12 points
of your life most affected each area + all other aspects  
        
among 6 areas
by your condition    of life using scale 0 - 10
Table 1 PGI for a young man with back pain [5]
Stage 1: area or activity affected
Stage 2: 
score of 10
Stage 3: spend  
your 12 points Final score
1. Work suffers 1 × 2/12 = 0.17
2. Makes me moody 3 × 2/12 = 0.50
3. Always thinking 3 × 1/12 = 0.25
4. Can’t play with kids 5 × 4/12 = 1.67
5. My sex life suffers 7 × 2/12 = 1.17
6. All other aspects of your life not mentioned above 9 × 1/12 = 0.75
Total 4.5
Abbreviation: PGI, Patient-Generated Index.
Figure 2 Stages of the SEIQoL.
Stage 2 
 Rate your current status 
Stage 1 
           using a VAS Stage 3 
     List 5 areas of life 
 30 x 
  most important to you Rate your overall QoL given the 
 in assessing your QOL  hypothetical profile using a VAS 
 Rate your current overall 
*Repeat 30 times to rate 30 hypothetical profiles. 
    QoL using a VAS 
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all 25 constructs using a 3-point scale: + (positive),
– (negative), 0 (neutral), or NA if the relationship
cannot be given meaning. The maximum numbers
of elements and constructs are 20 and 25, respec-
tively, giving a possible total of 500 scores. The
overall QoL score, ranging from 0 to 100, is derived
using factor analysis and incorporates three ele-
ments: 1) you as you are now; 2) you as you were
before treatment; and 3) you as you wish you were
[9].
AQLQ. The AQLQ was developed by Juniper et
al. in 1991 [10]. The AQLQ is a disease-speciﬁc,
hybrid instrument that contains ﬁxed and elicited
items. When developing the instrument, the
researchers noticed that the physical activity
domain had a large variation in item importance
among patients. Thus, the physical activity limita-
tion domain of the questionnaire includes ﬁve indi-
vidualized questions. The remaining 6 items within
the physical activity domain are predeﬁned, along
with the items in the other three domains: symp-
toms (12 items), emotions, environmental stimuli (4
items), and emotional function (4 items).
During the ﬁrst visit, subjects are asked to list
activities in which they were limited by asthma in
the past 2 weeks, and 26 activities are offered as
probes (Fig. 4). Of the activities that are identiﬁed,
subjects are then asked to choose the 5 activities
that are most important to them, and these consti-
tute 5 of the 11 items of the activity domain for each
subject for the duration of the study. Subjects are
then asked to rate the extent to which they have
been limited in that activity during the past 2 weeks
using a 7-point Likert scale. The same rating scale
applies to all other items in each domain. The
AQLQ is a nonweighted instrument. Thus, all the
items are equally weighted. A mean score per item
for each domain is calculated, as well as for overall
QoL. Both the domain and the overall score range
from 1 to 7, where 1 = worst QOL and 7 = best
QOL. Overall QoL score equals the mean score for
all the items.
To assess the psychometric properties of the elic-
ited portion of the AQLQ, Juniper et al. [11] devel-
oped a standardized version of the AQLQ, the
AQLQ(s), which replaced the ﬁve elicited activity
limitation areas with ﬁve generic activities: strenu-
ous activities, e.g., running and exercising; moder-
ate activities, e.g., walking and housework; social
activities, e.g., talking and visiting friends; work-
related activities; and sleeping. These ﬁve activities
were selected through a review of the original item
reduction data from the development of the AQLQ
and patient elicited areas from clinical trial
databases.
Psychometric Properties (see Table 2)
Reliability. The PGI and the SEIQoL have shown
to have adequate test–retest reliability, within Pear-
son’s correlation >.70 [7,12,13]. Nevertheless,
unlike the SEIQoL, the PGI does not have the intrin-
sic capability to test for internal reliability. Also, no
studies were found that assessed the PGI’s internal
reliability. Six studies have shown the SEIQoL to
have good internal reliability, ranging from .6 to .9
[8,14–18]. Currently, there are no studies that have
measured the Repertory Grid’s reliability. Juniper et
al. compared the psychometric properties of the
original AQLQ’s activity limitation domain with the
AQLQ(s)’ generic activities and found that both
had similar and adequate internal reliability prop-
erties, with between-subject SDs of ∼.7, within-
subject SDs of ∼.3, and internal Cronbach’s coefﬁ-
cients of ∼.9 [11].
Validity. Several studies found the PGI to have
mild to moderate correlation with clinical measures,
the SF-36, and condition-speciﬁc instruments such
as the overall Dermatology Life Quality Index
(DLQI) [7,12,19,20]. A study conducted by Ruta et
al. [7] found that the subgroups of patients express-
ing similar health concerns achieved higher correla-
tions of the PGI score with 7 of 8 SF-36 scales
compared to the sample as a whole, suggesting the
PGI has good criterion validity. Nevertheless, there
was a lack of correspondence between SF-36 scales
and patient subgroups [7]. Stepwise multiple regres-
sion explained some of the variation in PGI scores;
however, further research needs to be conducted to
afﬁrm the PGI’s criterion validity [7,12].
The SEIQoL, on the other hand, has not been
compared to standard instruments. To assess its cri-
terion validity, scores derived from elicited cues and
weights were compared to those scores ascertained
Figure 3 Stages of the Repertory Grid
Stage 1         Stage 2           Stage 3  
Interviewer provides
17 fixed elements
plus
12 fixed constructs 
Patient adds up to 3 elements.
Interviewer elicits up to
13 constructs
using triad technique 
Patient rates association
b/wn each element & each
construct using 3-point 
scale: +, -, 0 
Figure 4 Stages of the Individualized Section of the AQLQ.
Stage 1      Stage 3 
 
List activities in which Stage 2 Rate the extent to which 
you were limited by Choose 5 activities that are you have been limited in
asthma in the most important to you each activity using a 
past two weeks Likert Scale,  1 to 7 
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by eliciting relative cue weights for a series of pro-
vided cues obtained from traditional measures. A
low correlation <0.25 was found, suggesting that
individualized measures address different aspects of
HRQoL than semi-individualized measures [8]. The
SEIQoL, unlike the PGI, has shown high content
validity (.72–.88) [8,14–18]. Tully et al. [21] found
a negative correlation of .4 to .8 between the total
PGI scores and the relevant AIMS scales for sub-
groups of respondents expressing similar concerns
on the PGI, suggesting that the PGI has good con-
tent validity. Nevertheless, two studies found that
half of the patients mentioned areas that were part
of the standardized instrument, DLQI [19], or
mentioned areas that were solely on the trigger list
provided [20]. The PGI also did not signiﬁcantly
meet the trend of the hypothetical constructs cre-
ated by researchers to assess its construct validity
[7,12,21].
Thunedborg et al. [9] found that 58% of the
patients’ triplet of elements (now, before, and ideal)
was consistent with the direction assigned to the
factors in the factor analysis, suggesting that the
Repertory Grid has good construct validity. Never-
theless, no other validity tests have been conducted
for the Repertory Grid. Thus, its validity remains
questionable.
The AQLQ and the AQLQ(s) have been shown
to have similar criterion and construct validity. All
of the activities that were selected by three or more
patients in the AQLQ were covered by the ﬁve
generic activities in the AQLQ(s). The mean activ-
ity domain score was lower with the AQLQ than
with the AQLQ(s), but only by 0.2, which may not
be clinically signiﬁcant. The AQLQ and the
AQLQ(s) also had similar correlation with clinical
measures and the SF-36 for both cross-sectional
and longitudinal construct validity [11]. Neverthe-
less, these ﬁndings are not surprising, because the
AQLQ and the AQLQ(s) share six overlapping
domains and the activity domain of the AQLQ(s)
is composed of items frequently mentioned by
asthma patients.
Responsiveness. Neither the Repertory Grid
nor the individualized portions of the AQLQ have
been tested for responsiveness. The PGI was found
to have less responsiveness than condition-speciﬁc
instruments and the same [12] to less responsiveness
than the SF-36 [22]. Nevertheless, the PGI was
more sensitive to change when compared to the
EuroQoL [23]. One study assessed the SEIQoL’s
responsiveness and found that in comparison to the
control group, the patient group showed greater
improvement in QOL scores [13].
Practicality. Signiﬁcant sociodemographic differ-
ences between patients that could complete the PGI
correctly and those who could not have been found
[7,12,20]. Patients that were lower on the sociode-
mographic scale, e.g., poor or less educated, were
less likely to comprehend the PGI. Tully et al. [21]
found that all respondents interviewed showed lack
of understanding of the phrase “all other aspects”
and many respondents showed lack of understand-
ing and incorrect usage of ranking scales and point
allocation. No studies have reported the PGI’s com-
pletion time.
The SEIQoL has also been found to be time-
consuming and somewhat cumbersome [13,16],
especially in patients with cognitive impairment
[14]. The completion time for the SEIQoL is 30 to
45 minutes. To make the instrument less cumber-
some, Browne et al. [17] developed the direct
weighting procedure (SEIQoL-DW). The SEIQoL-
DW, also known as the short version of the SEIQoL,
replaces the weighting procedure with a pie chart
format, which consists of ﬁve interlocking colored
disks, with ﬁve segments representing the chosen
cues. Respondents adjust the disks until the size of
each colored segment cue corresponds to its relative
importance [17]. The SEIQoL-DW was found to be
less time-consuming and cumbersome than the
SEIQoL, taking 5 to 15 minutes to complete, with a
100% completion rate [17,18]. The validity and
reliability of the SEIQoL-DW also was found to be
comparable to the SEIQoL [17], and it has been
used in a variety of patient populations, e.g., HIV/
AIDS [23], cancer [24], mental illness [25], cardiac
[26], and multiple sclerosis [27]. Nevertheless, con-
vergence tests have shown that the SEIQoL and
SEIQoL-DW are not interchangeable, suggesting
that one measure cannot be used as a surrogate for
another [17,18].
The Repertory Grid’s completion time is approx-
imately 60 minutes [9]. No studies have been per-
formed to further assess its practicality. The AQLQ,
on the other hand, is relatively short. The initial
consultation takes 10 minutes to complete and
5 minutes thereafter. Nevertheless, the elicited sec-
tion of the AQLQ may contain missing data, mak-
ing the section unusable. Muntner et al. [28] found
that 7 of 115 patients were not able to properly ﬁll
out the activity domain. Garratt et al. [29] also
found that the mailed version of the AQLQ had the
largest amount of missing data in the activity limi-
tation domain. An average patient failed to com-
plete 0.98 items in the activity limitation domain
versus 0.2 in the other domains. They also found
that within the activity limitation domain, the indi-
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vidualized section had a mean number of 0.89 miss-
ing responses versus 0.09 in the standardized
section. Also, only 73% of the patients completed
the individualized section and 11% had missed all
ﬁve of the items. The authors concluded that the
individualized section was not valid and excluded it
from the analysis [29].
Current Use in the Literature
The PGI and the SEIQoL have been used in several
different patient populations and disease states. The
PGI has been used in patients with low back pain,
menorrhagia, peptic ulcer disease, varicose veins
[7,12], atopic dermatitis [19], arthritis [20], and
obstructive sleep apnea [22]. The SEIQoL has been
used in patients with peptic ulcer disease [8], arthri-
tis [13], amyotrophic lateral sclerosis [15], and hip
arthroplasty [16]; in healthy people; and in the eld-
erly [14]. The SEIQoL has also been used in a pilot
study among postmenopausal women, measuring
feasibility and participant satisfaction [30]. Never-
theless, study data have not been published. The
PGI and the SEIQoL have only been used in obser-
vational studies and have not been used in a clinical
trial setting. The Repertory Grid was used in a pilot
study among patients with generalized anxiety dis-
order who were enrolled in a clinical trial, but the
results are unknown, and it has only been used in
this one patient population [9]. The AQLQ has
been used in many asthma clinical trials; however,
the usefulness of the individualized section of the
AQLQ has not been explored in the literature.
Discussion
The applicability of patient-generated outcome
measures in a clinical trial setting remains question-
able. Based on the current observational studies
conducted using the PGI, it can be concluded that
the measure may not be as reliable and valid as cur-
rent traditional measures. The PGI also has not
been shown to be responsive or practical. Studies
have found that more than half of the subjects tak-
ing the PGI mentioned cues that were part of the
trigger list or covered by standardized instruments,
making its added value unclear. The PGI allows
respondents to address “nonhealth” aspects of
QoL, which may further limit its applicability in a
clinical trial setting, because in a clinical trial
“health-related” aspects of QoL are of interest.
Another limitation of the PGI is that it does not pro-
vide a form of standardization that is needed for
making comparisons across individuals and esti-
mating population effects. Even though the instru-
ment enables respondents to customize the
questionnaire to address their personal needs and
expectations, the results cannot be pooled for com-
parison, making the instrument’s applicability in a
clinical trial setting poor.
The SEIQoL, on the other hand, has shown to be
reliable and valid in several patient populations and
has been shown to be responsive; however, the prac-
ticality of the SEIQoL is poor owing to its long com-
pletion time and cumbersomeness. The short
version of the SEIQoL, the SEIQoL-DW, takes less
time to complete, making its use in a clinical trial
more feasible. Nevertheless, the SEIQoL-DW has
not been used in a clinical trial and does not allow
results to be pooled for making comparisons and
estimating population effects. Further research
needs to be conducted to determine its applicability
in a clinical trial setting.
The Repertory Grid, unlike the PGI and the
SEIQoL, has not been used in more than one patient
population, and its psychometric properties have
not been well studied. Its use in QoL research
remains questionable. The AQLQ has been used in
several clinical trials and its psychometric properties
have been well established. Nevertheless, the value
of the individualized section of the AQLQ has not
been addressed in the literature. The standardized
version of the AQLQ, AQLQ(s), has shown to have
similar psychometric properties as the AQLQ and,
in addition, avoids the problem of missing data.
Thus, the AQLQ(s) appears to be more practical
and applicable than the AQLQ for use in clinical
trials.
A limitation of our review was our inability to
access studies that have not been published or are in
progress. We did attempt to capture some of this
information by contacting instrument developers
and other experts in the ﬁeld. Nevertheless, work
carried out in smaller, unknown studies may have
been overlooked.
A major weakness of patient-generated outcome
measures is their failure to provide a form of stand-
ardization needed for comparison of results. An
alternative to patient-generated outcome measures
may be computerized adaptive testing or dynamic
health assessments. Computerized testing software
is used to not only enable respondents to determine
their overall health status by tailoring questions
to meet their level of health, but also score all
respondents on a standard metric, thus allowing
comparison of results [31]. Dynamic health assess-
ments may provide a way to capture individual
HRQoL in a clinical trial with less respondent
burden [32].
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In conclusion, patient-generated outcome meas-
ures, although conceptually appealing, may not be
appropriate as sole measures of HRQoL in a clinical
trial setting. Further research needs to be performed
to determine their validity and applicability in a
clinical trial setting. In patient populations where
there is a large variation in health status, these
measures may be useful as adjuncts to traditional
health status measures. Nevertheless, because
patient-generated outcome measures calculate indi-
vidual QoL scores, making comparisons across
individuals and grouping of scores may be very dif-
ﬁcult. Thus, their most important role may not be in
a clinical trial setting, but in the consultation proc-
ess, where the practitioner can formulate and mon-
itor therapeutic plans based on the life areas elicited
by the patient. These measures may also be of value
in the development of new questionnaires and
instruments.
We thank Dr Ciaran O’Boyle and Dr Elizabeth Juniper for
their insightful comments.
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